For 54 years, PAAB has been recognized by Health Canada as the Advertising Preclearance Agency for health professional directed health product advertising.
Do drug ads have the potential to deliver value to health professionals?
Time is precious, and the volume of medical literature is vast. Health professional-directed drug advertising can deliver value by generating awareness of emerging therapies, uses, and data. This awareness can aid health professionals in effectively targeting their ongoing professional development activities.
How can this potential value be unlocked?
The full potential of drug advertising is realized only when it provides comprehensive, credible information that enables health professionals to make informed judgments about the content’s validity and applicability to their practice. The PAAB logo signifies that this potential has been unlocked through a rigorous, independent review process, ensuring that health professionals receive the complete story.
Scroll down to learn more about preclearance
The PAAB logo provides confidence that the materials have undergone independent review. They have been vetted through our preclearance mechanism to ensure rigorous evidentiary support for all claims; for balance between risk and benefit; for consistency with the current marketplace and current medical practice; and for consistency with the Health Canada approved label.
Your perspective is important to us. Get involved in shaping the standards that are applicable to healthcare professional directed drug advertising? You can also get involved in shaping the standards that are applicable to patient information materials generated by the pharmaceutical industry. Simply express your interest to participate on future PAAB advisory committees in an email to patrickm@paab.ca.
COMMENTS
Materials that bear the PAAB logo signify that they have undergone a rigorous independent review process, ensuring that they are:
All claims contained therein are supported by valid and representative evidence. Annual renewal ensures that claims continue to reflect the marketplace. Clinical trials featured in advertising are accompanied by transparent disclosure of key study limitations to enable you to efficiently determine whether the study is of value to you.
The PAAB Code requires transparent disclosure of risk information from the promoted medication’s Health Canada approved product monograph so as to promote optimal patient selection.
Advertising may not be inconsistent with the Health Canada approved product monograph.
PAAB adjudicates complaints on healthcare professional advertising for healthcare products such as prescription drugs, non-prescription drugs, natural health products, and homeopathy products. You can launch a complaint.
In order to ensure that PAAB meets the needs of Health Canada, health professionals and patients, regular reviews of the PAAB Code are undertaken. PAAB would like to invite Canadian health professionals to be part of this process by registering with us.
The PAAB runs a preclearance mechanism. Preclearance is a process during which the advertising is reviewed and revised as many times as necessary for the advertising to be deemed to meet all provisions in the PAAB Code of Advertising Acceptance. We refer to it as preclearance (rather than simply clearance) because the entire process takes place before the advertising is used in the marketplace. Canada is one of the few jurisdictions in the world that employs such a robust preventative approach to keep the market clean of misleading advertising. Many other countries rely solely on a monitoring mechanism to react to misleading advertising some time after market exposure. PAAB also employs a monitoring mechanism but this is complementary to preclearance rather than in place of it.
In a world overflowing with medical content, diligent health professionals must be selective about where they invest their research, reading, and development hours. While health professionals do not typically base their medical practice on drug advertising, health professional-targeted drug ads play a crucial role in creating initial awareness of emerging therapies, uses, and issues. This awareness sparks ideas about which emerging therapeutic research you may want to explore further.
We ensure that health professional-targeted advertising contains the information you need to make informed conclusions about the validity and generalizability of the data, allowing you to quickly assess its relevance to your practice. On the frontier of healthcare, no study is perfect or universally applicable. That’s why we prioritize transparency in conveying study limitations, enabling you to focus on the science and decide whether the information is worth pursuing further—either within the ad or through independent research.
Health professional judgement and prescribing behaviour may be influenced by drug advertising. This may even be the case in the subgroup of health professionals who consider themselves to be “immune” to advertising. Note that even health professionals who refuse to accept visits from drugs representatives are exposed to advertising. PAAB believes that advertising plays an important role in providing timely information to health professionals. The key is that it must be accurate, complete, clear and designed to promote credibility and trust. This is where the PAAB preclearance mechanism fits in.
We not only ensure that study limitations and relevant drug risks are clearly disclosed in the advertisement, but we also do so in a way that helps you quickly determine whether the information benefits your practice. That is our commitment to you. Ultimately, we aim to empower you to focus on what truly matters: matching the right products with the right patients. Consider making this commitment to yourself: when it comes to drug promotion, let the PAAB logo be your filtering criterion. If you don’t see it, move on.
Yes. Although the PAAB is independent from both Health Canada and the pharmaceutical industry, the PAAB is the only regulator whose preclearance service is recognized by Health Canada for advertising directed to health professionals. Additionally, the member publishers of the Canadian Association of Medical Publishers (CAMP) have committed that all health product advertising subject to the PAAB code carry the PAAB logo. PAAB benefits from having open lines of communication with Health Canada. In fact, Health Canada attends meetings of the PAAB Board of Directors as a non-voting observer. See the composition of the PAAB Board of Directors. This might be the first time you have heard about PAAB. That’s because PAAB has been quietly effective. We’ve been running our preclearance mechanism in Canada for over 40 years. See our timeline from inception to now.
Click here to see the resources on our website which are particularly relevant to you. For example, we’ve collated a list of documents that outline some of the federal drug advertising regulations which impact you directly. Did you know that health professionals need to be cautious not to contravene federal drug advertising regulations when promoting medical services in the context of medicines?
Are you a representative from a healthcare professional association, institution, or university? Contact us at info@paab.ca if you’d like PAAB to come visit your group to perform a presentation about what we do and why we do it.
Click here to see the resources on our website which are particularly relevant to you. For example, we’ve collated a list of documents that outline some of the federal drug advertising regulations which impact you directly. Did you know that healthcare professionals need to be cautious not to contravene federal drug advertising regulations when promoting medical services in the context of medicines?
PAAB adjudicates complaints on health professional advertising for health products such as prescription drugs, non-prescription drugs, natural health products, and homeopathy products. You can launch a complaint.
Are you a representative from a health professional association, institution, or university? Contact us at info@paab.ca if you’d like PAAB to come visit your group to speak about what we do and why we do it.
Did you know that health professionals need to be cautious not to contravene federal drug advertising regulations when promoting medical services in the context of medicines? Click here to see the resources on our website which are particularly relevant to you.
In an effort to constantly serve our clients better, PAAB has unveiled a new electronic submission process(eFiles). Effective January 2, 2008 all submissions will have to be submitted via the eFiles system. Please have a Senior Official (Director level) send an email to the administration team at review@paab.ca with the contact information of the person(s) who will be designated as administrator(s) for your company. Click on eFiles, on the menu, then eFiles Tutorial for a tutorial on how eFiles works.
Please contact the admin team at PAAB if you need assistance with eFiles
The Accelerated Preclearance Pathway
Learn more and share your feedback by April 14
Click here to provide feedback